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Abstract
Background: Respiratory Syncytial Virus (RSV) infection is usually restricted to the respiratory epithelium. Few
studies have documented the presence of RSV in the systemic circulation, however there is no consistent
information whether virus detection in the blood correlates with disease severity.
Methods: Balb/c mice were inoculated with live RSV, heat-inactivated RSV or medium. A subset of RSV-infected
mice was treated with anti-RSV antibody 72 h post-inoculation. RSV RNA loads were measured by PCR in peripheral
blood from day 1-21 post-inoculation and were correlated with upper and lower respiratory tract viral loads, the
systemic cytokine response, lung inflammation and pulmonary function. Immunohistochemical staining was used
to define the localization of RSV antigens in the respiratory tract and peripheral blood.
Results: RSV RNA loads were detected in peripheral blood from day 1 to 14 post-inoculation, peaked on day 5
and significantly correlated with nasal and lung RSV loads, airway obstruction, and blood CCL2 and CXCL1
expression. Treatment with anti-RSV antibody reduced blood RSV RNA loads and improved airway obstruction.
Immunostaining identified RSV antigens in alveolar macrophages and peripheral blood monocytes.
Conclusions: RSV RNA was detected in peripheral blood upon infection with live RSV, followed a time-course
parallel to viral loads assessed in the respiratory tract and was significantly correlated with RSV-induced airway
disease.
Background
RSV is the most common cause of acute lower respira-
tory tract infection in infants and the leading cause of
hospitalization in this age group [1,2]. The clinical mani-
festations of the disease are thought to be a result of the
direct viral cytopathic effect on the respiratory epithe-
lium and the host immune response leading to signifi-
cant inflammation of the respiratory tract [3-6].
Few reports, mostly in immunocompromised patients,
have documented the possible dissemination of RSV
outside the respiratory tract [7-12]. However, there are
no studies that have examined in detail the potential
relation between the presence of RSV RNA in the
systemic circulation and whether it is correlated with
RSV-induced acute airway disease. Other RNA respira-
tory viruses, such as the SARS-coronavirus, rhinoviruses,
seasonal influenza or avian influenza (H5N1) viruses
have been associated with detection of viral RNA in
whole blood, blood fractions, serum or plasma in a sub-
set of patients with acute or fatal disease, suggesting
that viral dissemination may be associated with poor
outcomes [11,13-17].
We used a well-established experimental model of
RSV infection to examine the significance of RSV disse-
mination in disease pathogenesis. We determined 1)
whether RSV could be detected in peripheral blood dur-
ing the acute phase of the disease, 2) its time course of
detection compared with the upper and lower respira-
tory tract, and 3) whether the RSV-induced systemic
cytokine response and clinical parameters of disease
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were correlated with blood RSV RNA loads.
Materials and methods
Virus, growth conditions and RSV quantification
Human RSV A2 (ATCC-1540) was grown on Hep-2
cells. RSV loads from brochoalveolar lavage (BAL) and
nasal wash samples were measured by plaque assay with
lower limit of detection of 1.7 log10 PFU/mL as
described [18,19]. RSV loads in BAL, whole lung, nasal
wash and peripheral blood samples were measured
by real-time PCR with lower limits of detection of
10 copies/reaction, as described [20,21].
Animals and Inoculation
Seven-week old BALB/c mice were inoculated with 100
μL1 0
7.6-8.3 PFU/mL of RSV, or heat inactivated RSV as
described [18,19,21]. Uninfected controls were inocu-
lated with 100 μL of 10% EMEM. All experiments were
performed following the Institutional Animal Care and
Research Advisory Committee guidelines.
Experimental design and sample collection
Four to six mice per time point, per group were
evaluated on days 1, 3, 4, 5, 6, 7, 10, 14 and 21 after
inoculation. Mice were inoculated with: 1) live RSV; 2)
heat-inactivated (HI)-RSV or 3) EMEM. In a second set
of experiments, a group RSV-infected mice was treated
with an anti-RSV monoclonal antibody (moAb; motavi-
zumab) administered intraperitoneally (IP; 2.50 mg/per
mouse or 100 mg/kg in 100 μl) at 72 h post-inoculation
[22]. Mice were euthanized with an IP injection of keta-
mine and acepromazine prior to cardiac puncture.
B l o o d ,n a s a lw a s h ,B A La n dw h o l el u n gs a m p l e sw e r e
collected for viral load quantification by culture and
real-time PCR. To assess the severity of the pneumonia
a n dt h ed i s t r i b u t i o no fR S Va n t i g e n si nt h el u n g sw e
performed lung histologic evaluation and immunohisto-
chemical (IHC) staining. Systemic CCL2, CXCL1 (innate
immunity cytokines), IFN-g (Th-1) and IL-4 (Th-2)
mRNA expression was measured sequentially from days
1 to 7 post-inoculation.
Blood samples (~500 μL/mouse) were obtained by car-
diac puncture, mixed in RNA stabilization reagent (Tem-
pus® solution; ABI, Foster City, CA) and stored at -20°C
until analysis. On day 5, the peak of RSV disease in this
model [18,19,21], peripheral blood samples from two
separate experiments were placed in EDTA tubes (BD
vacutainer) for RSV antigen detection by IHC staining.
Nasal wash and BAL specimens were obtained by infus-
ing 500 μl of 10% EMEM through a 25-gauge needle as
previously described [19,23]. Lungs were rinsed with
3 mL of PBS 1× prior to sample collection and fixed with
either 10% buffered formalin for histologic evaluation or
placed in RNAlater stabilization reagent (Quiagen, Valen-
cia, CA) for viral load quantification [20,21]. Results
represent aggregate data from four independent experi-
ments; each included 4-6 mice per time-point per group.
Pulmonary Function Tests and Lung Histopathology
Enhanced pause (Penh), a measure of airway obstruction
(AO), was assessed daily until day 10, and then weekly
until day 21 using a whole-body plethysmograph (Buxco
Inc, Wilmington, NC) [19,21,24]. For histologic evalua-
tion lung samples were fixed in formalin, embedded in
paraffin, and whole-mount sections were stained with
H&E. Histopathologic scores (HPS) were determined by
a pathologist who was unaware of the infection status of
the mice. This scoring system has been previously vali-
dated in the RSV mouse model [18,19,21].
Immunohistochemical Staining (IHC)
Whole lung samples and blood cells were processed fol-
lowing a similar protocol. Briefly, samples were fixed in
10% buffered formalin for 30 min and re-suspended in
liquefied histogel. Four-μm sections blocks were cut and
placed onto positively charged slides. After deparafiniza-
tion, sections were incubated at 95-100°C for 36 min for
antigen retrieval. After antibody block, a primary goat
anti-RSV polyclonal antibody (Biodesign International,
Saco, ME) was incubated for 1 h at room temperature
followed by incubation with a rabbit secondary antibody
(Abcam, Cambridge, MA) and with horseradish peroxi-
dase conjugated anti-rabbit for 24 min (Ventana, Tuc-
son, AZ). Slides were developed using a DAB
chromogen-based detection kit from Ventana and hema-
toxylin used as a counterstain. Lung sections from RSV
infected and uninfected mice were used as positive and
negative controls respectively.
Real-time Polymerase Chain Reaction (PCR)
One sample per mouse was evaluated as a single speci-
men and RNA detection performed by an operator who
was blinded to the sample’s identification. Samples sub-
jected to RNA detection met the requirements for quan-
tity and quality/purity assessed with the NanoDrop
spectrophotometer (Wilmington, DE). No false positives
were detected in a total of 1,007 samples analyzed. RNA
was obtained from nasal wash, BAL and whole-lung spe-
cimens and extracted using ion-exchange mini-columns
(Qiagen, Valencia, CA). Whole blood RNA was
extracted using the Tempus Spin RNA kit (ABI, Foster
City, CA) according to the manufacturer’s instructions.
RNA reverse transcription, amplification and quantifica-
tion of a conserved region of the N gene was performed
as described [20-22].
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Quantification of blood IFN-g (Mm 00801778_m1), IL-4
(Mm 00445259_m1), KC/CXCL1 (Mm 00433859_m1),
MCP-1/CCL2 (Mm 99999056_m1), was performed by
real-time PCR in ABI 7300 HT sequence detector. Rela-
tive mRNA expression was calculated using the com-
parative ΔΔCt method [21,25,26].
Statistical Methods
Sigma Stat 2008 software (SPSS Science, San Rafael,
CA) was used for analyses. Differences between groups
were tested using the one-way ANOVA or Kruskal-
Wallis test according to data distribution. When these
tests demonstrated a significant difference between
groups (p < 0.05), the Tukey test to correct for multi-
ple comparisons was used. Pearson or Spearman Rank
Order test were used for correlations. In all analyses, a
two-tailed p value < 0.05 was considered to be statisti-
cally significant.
Results
Dynamics of RSV RNA detection in the in the upper and
lower respiratory tract
We first assessed the time course of RSV RNA detection
by real-time PCR and the presence of replicative virus
by plaque assay in the upper (nasal wash) and lower
respiratory tract (BAL and whole lung) of RSV infected
mice and sham inoculated controls. In mice infected
with live RSV, RSV RNA loads measured in whole lung
and BAL samples were comparable and significantly
higher than RSV RNA loads measured in nasal wash
samples from day 1 to 10 post-inoculation. By day 10,
RSV RNA was no longer detected in nasal wash speci-
mens but remained significantly elevated in whole lung
samples until day 21 post inoculation (Fig. 1A).
To document the presence of replicative virus, viral
loads were measured by plaque assay in BAL and nasal
wash samples during the acute infection. Viral loads in
both BAL (p = 0.03) and nasal wash samples (p < 0.01)
Figure 1 Dynamics of RSV RNA detection in the upper and lower respiratory tract. RSV was measured in nasal wash (NW), bronchoalveolar
lavage (BAL), whole lung (WL) samples from 4-14 mice per time point per group from 4 independent experiments. Mice were intranasally
inoculated with 10
7.6-8.3 PFU in 100 μL of RSV or sterile media (non-infected controls). (A) Compared with non-infected controls, which had no
RSV RNA detected at any time point, RSV RNA loads detected by real-time PCR in WL and BAL were significantly higher than RSV loads detected
in NW. Values represent means (± SD) of RSV log10 RNA copies/mL. Comparisons were made by One way ANOVA; * p < 0.001. (B). By plaque
assay, RSV loads were significantly higher in BAL samples compared with NW on days 1 and 5 post-inoculation. From days 1 to 5 only viral loads
measured in BAL samples were higher than those assessed in non-infected controls. Values represent means (± SD) of RSV log10 PFU/mL. One
way ANOVA was used for comparisons; * p < 0.05.
Torres et al. Respiratory Research 2010, 11:125
http://respiratory-research.com/content/11/1/125
Page 3 of 11increased from day 1 to days 3-4 post-inoculation, pro-
viding evidence of active viral replication, then
decreased and remained below the limit of detection of
the assay after day 7 post-inoculation, as previously
shown in this model [18,19,21]. Overall, viral loads mea-
s u r e di nB A Ls a m p l e sw e r eh i g h e rt h a ni nn a s a lw a s h .
This difference reached statistical significance on days 1
and 5 post-inoculation (Fig. 1B).
As previously reported, mice inoculated with HI-RSV
had significantly lower RSV RNA loads in BAL and
whole lung samples compared with mice infected with
live RSV and no viable virus was recovered by plaque
assay (data not shown) [21].
RSV RNA is detected in peripheral blood during acute
RSV infection and follows a time-course similar to RSV
RNA loads measured in the respiratory tract
Once we characterized in detail the dynamics of RSV
RNA detection in the upper and lower respiratory tract,
we first determined whether RSV RNA could be
detected in peripheral blood and second we quantitated
the amount of virus present in mice infected with live-
RSV, heat-inactivated RSV and sham inoculated con-
trols. From day 1 to 14 post-inoculation RSV RNA was
detected in blood samples only in mice infected with
live RSV. Detection of peripheral blood RSV RNA sig-
nificantly increased from 15% of positive samples on day
1, to 72% of samples on day 4, peaked on day 5 with
detection in 100% of samples and decreased over time
with no blood RSV RNA detected in any RSV-infected
mouse beyond day 14 (Fig. 2A). In mice infected with
live-RSV blood viral loads gradually increased from 0.8
(± 2.02) log10 RSV RNA copies/mL on day 1, to 4.3
log10 RSV RNA copies/mL on day 5 (± 1.46) post-inocu-
lation. The highest blood RSV RNA loads were detected
on days 4-7, which represent the peak of clinical disease
severity in this model (Fig. 2B) [18,19,21]. Mice inocu-
lated with HI-RSV or sham-inoculated controls had
no RSV RNA detected in the blood at any time point
(n = 110 samples evaluated).
The dynamics of RSV RNA in the blood mirrored
RSV loads detected in the respiratory tract, although at
significant lower concentrations (p < 0.05). On day 5,
the peak of RSV RNA detection in peripheral blood,
blood RSV RNA loads significantly correlated with nasal
wash and whole lung RSV RNA loads (p < 0.05; r =
0.65-0.76), but not with those measured in BAL
specimens.
RSV Antigens are detected in Peripheral Blood Monocytes
We attempted to grow RSV from peripheral blood sam-
ples on days 4 and 5 post-inoculation, but the standard
plaque assays performed did not yield positive results.
Alternatively and to confirm the presence of RSV in
peripheral blood using a different method we performed
immunohistochemical (IHC) staining of blood immune
cells obtained from RSV infected mice and non-infected
controls. One specimen per mouse (4 mice per group)
from two independent experiments was harvested indivi-
dually on day 5 post-inoculation. Using an anti-RSV
polyclonal antibody, IHC staining demonstrated focal
and strong positive signal for RSV antigens in the cyto-
plasm of peripheral blood monocytes in 5 out of 8 RSV
infected mice (Fig. 3A-C). The identification of mono-
cytes in peripheral blood was based on their morphology
(small cells, with small cytoplasm and small vacuoles)
and was performed by an experience pathologist una-
ware of the infection status of the animals. Cell-blocks
from uninfected controls (n = 6) did not demonstrate
any positive staining (Fig. 3D). Three different patholo-
gists reviewed the slides in a blind fashion and they all
agreed with the results.
Systemic Cytokine Profiles During Acute RSV Infection
Once we identified peripheral monocytes bearing RSV
antigens, we assessed the systemic expression of CCL2/
MCP-1 and CXCL1/KC, which are chemoattractant for
monocytes and neutrophils, and IFN-g and IL-4, as
representative examples of Th-1 and Th-2 cytokines.
Blood expression of these innate and adaptive immunity
cytokines, all implicated in the pathogenesis of acute
RSV disease [27-29], were sequentially measured from
day 1 to 7 post-inoculation. In addition, we determined
whether the systemic expression of these cytokines cor-
related with RSV RNA loads measured in peripheral
blood. Experimental groups included mice inoculated
with live RSV, HI-RSV, and non-infected controls
(Fig. 4A-D).
Compared with non-infected controls and mice inocu-
lated with HI-RSV, blood CCL2 and CXCL1 mRNA
peaked on day 1 (p < 0.01), they leveled off on days 4-5,
and decreased by day 7 post-inoculation in mice
infected with live RSV (Fig 4A and 4B). On the other
hand, the systemic expression of IFN-g increased on day
4 and remained significantly elevated thereafter (Fig.
4C). IL-4 expression was below the limit of detection or
w a sd e t e c t e da tv e r yl o wl e v e l sf r o md a y1t o5 ,b u t
showed a significant increase on day 7 post-inoculation
compared with controls. Expression levels of these 4
cytokines were comparable in non-infected controls and
mice inoculated with HI-RSV at all time points evalu-
ated (Fig. 4A-D).
There was a significant but inverse correlation
between blood RSV RNA loads and blood expression of
CCL2 and CXCL1 on day 4 post-inoculation (p < 0.05,
r = -0.9/-1).
Torres et al. Respiratory Research 2010, 11:125
http://respiratory-research.com/content/11/1/125
Page 4 of 11Blood RSV RNA Loads Correlates with the Severity of
Acute RSV Disease
To determine the significance of blood RSV RNA detec-
tion in the context of disease pathogenesis, we assessed
disease severity by measuring pulmonary function
abnormalities and lung inflammation, and determined
whether they were correlated with peripheral blood RSV
RNA loads.
Penh values, a validated measure of airway obstruction
[18,19,21], were significantly increased in RSV-infected
mice compared with controls and mice inoculated with
HI-RSV from day 1 to 14 post-inoculation (p < 0.01) as
previously shown [19,21]. On day 5 post-inoculation,
Penh values in mice infected with live RSV (Penh; 1.45
± 0.35) were significantly higher than in mice inoculated
with HI-RSV (Penh; 0.58 ± 0.04) and non-infected con-
trols (Penh; 0.51 ± 0.08) (Fig 5.A). Penh values signifi-
cantly correlated with peripheral blood RSV RNA loads,
on day 4 (r = 0.67; p = 0.002), day 5 (r = 0.74; p =
0.002) (Fig. 5.B) and day 10 (r = 0.73; p = 0.005) post-
inoculation.
As we previously shown in this model, the severity of
airway obstruction gradually and significantly increased
from day 1 to day 5, the peak of airway disease [18-22].
Lung inflammation was assessed sequentially on days 1,
3, 4, 5, 6, 7, 10 and 14 post-infection. Compared with
Figure 2 Time-course detection of RSV RNA in peripheral blood during Acute RSV disease. RSV RNA was measured in peripheral blood
samples sequentially obtained in RSV infected mice, mice inoculated with heat-inactivated RSV and uninfected controls from day 1 to 21 post-
inoculation. Mice inoculated with HI-RSV and non-infected controls did not have RSV RNA detected in the blood at any time point evaluated.
Fig. 2. A The Y-axis represents the percentage of positive samples detected in each experimental condition and the X-axis the time points
evaluated. Numbers at each time-point represent the ratio of positive RSV RNA samples/total number of RSV-infected mice evaluated. RSV RNA
detected in blood significantly increased from day 1 to day 5 (Z-test, p < 0.001). Fig. 2. B. The Y-axis represents the peripheral blood RSV RNA
loads in log10 copies/mL over time. Blood viral loads in mice infected with live-RSV gradually increased from day 1 to day 5 post-inoculation, the
peak of viral detection and viral load quantification (One-way ANOVA p < 0.01).
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= 0-1), mice inoculated with live RSV showed signifi-
cantly greater HPS, with a dense inflammatory infiltrate
and severe pneumonia, which peaked on days 5-7 post-
inoculation (p < 0.01) (Fig. 6A; 1-8). To define the
distribution of RSV antigens in the lungs, IHC staining
was performed using a polyclonal RSV antibody. Immu-
nostaining showed an increasingly positive stain for RSV
in the alveolar epithelium from day 1 to days 3-4 and
decreased by days 6-7 post-inoculation. On the other
hand, IHC in alveolar macrophages was negative on day
1, occasionally positive on day 3, strong and diffusely
positive on days 4 to 6 and also decreased by day 7.
Both the alveolar epithelium and alveolar macrophages
were negative for RSV staining on days 10 and 14 post-
infection (Fig 6A; 6A-H). In contrast to airway obstruc-
tion, there was no significant correlation between the
severity of lung inflammation (HPS) and blood RSV
RNA loads on day 5, illustrating the different time
course of these two parameters of disease severity
(Fig. 6.B).
Treatment with anti-RSV neutralizing antibody reduced
blood RSV RNA loads and improved acute airway
obstruction
To further assess the significance of blood RSV RNA
detection in disease pathogenesis, we determined
whether treatment with an anti-RSV moAb had an
effect on RSV RNA loads in peripheral blood. Treat-
ment with anti-RSV moAb at 72 hours post-inoculation
reduced both the duration and peak of blood RSV RNA
loads. Mice treated with the moAb had blood RSV RNA
loads detected only from day 4 to 7, and showed signifi-
cantly lower peak blood RSV RNA loads than non-trea-
ted RSV-infected mice on day 5. After day 6, RSV RNA
was no longer detected in the blood of any mouse trea-
ted with anti-RSV moAb (Fig. 7.A). In addition com-
pared with untreated RSV-infected mice, airway
obstruction was significantly reduced from day 4 (24
hours after treatment) to day 7 post-inoculation in RSV-
infected mice treated with the moAb. This difference
reached statistical significance on days 5 and 6 post-
inoculation (Fig 7.B).
Figure 3 RSV Antigens are detected in Peripheral Blood Monocytes by Immunohistochemical (IHC) staining. Peripheral blood was
collected in RSV-infected mice (n = 8) and non-infected controls (n = 6) from two independent experiments on day 5 post inoculation. Four-
micron sections were IHC stained for RSV with a polyclonal antibody. Fig. 3A-C demonstrates peripheral blood monocytes with positive staining
for RSV in the cytoplasm. Uninfected mice did not demonstrate any positive staining (Fig 3D).
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Our current understanding of the ability of RSV to spread
from the respiratory tract to the systemic compartment,
the time course of detection in peripheral blood, and
whether this has implications for disease pathogenesis is
limited. Using a mouse model of RSV infection, we found
that: 1) inoculation with live RSV was consistently asso-
ciated with detection of RSV RNA in peripheral blood; 2)
the time course of RSV RNA detection in peripheral blood
mirrored viral replication in the respiratory tract; 3) RSV
antigens were detected in peripheral blood monocytes and
lung alveolar macrophages during the acute phase of the
disease; 4) blood RSV RNA loads correlated with acute air-
way obstruction; and 5) administration of an anti-RSV
antibody significantly decreased the peak and duration of
peripheral blood RSV RNA loads and was associated with
improved airway obstruction.
Despite that the systemic spread of other paramyxo-
viruses has been frequently reported in the literature
[30,31], limited efforts have been dedicated to characterize
the significance of the detection of RSV in peripheral
blood in experimental models or patients with naturally
acquired infection. Three studies documented the pre-
sence of RSV RNA by real-time PCR in blood or periph-
eral blood mononuclear cells (PBMCs) in a subset of
neonates and children with RSV lower respiratory tract
infection [8-10]. In those studies, RSV RNA was also
found in the blood of a small percentage of children with
no evidence of RSV infection, and the association between
the detection of RSV in the blood and parameters of dis-
ease severity was inconclusive. On the other hand, the
detection of RSV RNA in the serum of a 2-month old with
RSV bronchiolitis was associated with the development of
hepatitis, indicating the possible dissemination of RSV in
Figure 4 Dynamics of Cytokine Expression in blood during Acute RSV Infection. Blood CCL2, CXCL1, IFN-g and IL-4 mRNA expression was
assessed from 4-6 mice per time-point per group in 3 independent experiments from days 1 to 7 after inoculation (Fig. 4A-D). Mice were
intranasally inoculated with live-RSV (solid grey bars), heat-inactivated RSV (hatched bars), or 10% EMEM (solid black bars). Values are represented
as means ± SD. One-way ANOVA was used for comparisons with non-infected controls mice (*p < .001). When this test demonstrated a
significant difference between groups the Tukey test to correct for multiple comparisons was used and considered significant for a p < 0.05.
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Page 7 of 11Figure 5 Blood RSV RNA detection Correlates with Acute Airway Obstruction. Fig. 5A. Airway obstruction assessed by Penh (Y axis)
significantly increased in mice infected with live RSV. On day 5 post-infection Penh values were significantly higher in RSV infected mice
compared with mice inoculated with HI-RSV and non-infected controls n = 12-16; One way ANOVA (p < 0.001). Fig. 5B. Penh values correlated
with peripheral blood RSV-RNA loads in RSV infected mice on day 5 post-inoculation (p < 0.01; r = 0.7; n = 14). Correlations were computed
using the Pearson’s correlation coefficient.
Figure 6 Lung Histopathology, RSV antigenic distribution and Correlations with blood RSV RNA loads. Fig 6A [1-8]: From days 1 to 7
post-inoculation, changes included perivascular edema and margination of neutrophils (day 1), which progressed to a sparse perivascular
infiltrate and later to dense perivascular and peribronchial/peribronchiolar inflammatory infiltrates composed of lymphocytes, macrophages and
scattered neutrophils. At its peak (days 5 to 7), these inflammatory infiltrates extended into surrounding alveolar septa in a stellate manner with
patchy involvement of the parenchyma and abundant macrophages, occasional lymphocytes and neutrophils in alveolar spaces. On days 10 and
14 the persistent changes included inflammatory infiltrates located around vessels and airways, consisting of lymphocytes and macrophages, but
no neutrophils or eosinophils. Fig 6A. [A-H]. By immunohistochemical staining (IHC) the alveolar epithelium showed a diffuse faint linear
staining on day 1, was stronger and widespread on days 3-4, and decreased by days 6-7. In contrast, alveolar macrophages’ IHC was negative on
day 1, occasionally positive on day 3, strong and diffusely stained on days 4 to 6 and decreased by day 7. Both the alveolar epithelium and
alveolar macrophages were negative for RSV IHC on days 10 and 14 post-infection. Fig 6B. Histopathologic scores significantly increased in mice
infected with live-RSV from day 1 (HPS mean ± SD; 5.7 ± 0.5) to day 5 (HPS 11.2 ± 2.1; p = 0.005), day 6 (HPS = 13.6 ± 2.3; p = 0.001) and day 7
(HPS = 10.7 ± 3.3; p = 0.02). There was no correlation between the peak of blood RSV RNA loads and lung inflammation.
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Page 8 of 11severe forms of the disease [12]. More recently, a study
conducted in hematopoietic cell transplant (HCT) recipi-
ents with respiratory virus-associated pneumonia showed
that compared with bronchoalveolar lavage (BAL) viral
loads, serum RSV, hMPV and influenza virus RNA loads
were significantly associated with the need for mechanical
ventilation and death, [11]. In the present study, the detec-
tion of peripheral blood RSV RNA gradually increased
from day 1 to day 5, with detection in 100% of samples on
day 5 post-inoculation which correlated with the peak of
clinical disease in this model defined by increased airway
obstruction.
The detection of RSV antigens by immunofluores-
cence prior to the implementation of PCR assays has
been previously described in PBMCs of children and
calves with acute RSV infection [32,33]. In agreement
with those studies, using IHC staining we identified per-
ipheral blood monocytes bearing RSV antigens on day 5,
the peak of RSV RNA detection in blood. Similarly, on
days 4 to 6 post-infection the distribution of RSV anti-
gens in the lungs was predominant in alveolar macro-
phages. Hence, it is possible that during the acute
infection immune cells bearing RSV antigens may
migrate from the respiratory tract to the systemic
Figure 7 Administration of anti-RSV moAb reduces the length and peak of RSV RNA detection in the blood and is associated with
improved airway obstruction. Fig. 7A. Blood RSV RNA loads were measured by real-time PCR on day 4, one day after treatment with anti-RSV
moAb, and then on days 5, 7, 10, 14 and 21 in mice infected with RSV (white circle), mice infected with RSV and treated 72 h later with anti-RSV
moAb (black triangle) and controls (not represented). Data shown are the result of two separate experiments each with 4 mice per time-point
per group. Comparisons were made by Mann-Whitney Rank Test *p < 0.05. Fig. 7B. Non-infected controls (grey circle), RSV-infected mice +
treated 72 h later with anti-RSV moAb (black circle) and RSV infected-non treated mice (black triangle) were evaluated for AO, by measuring
Penh via whole-body plethysmography. Penh was significantly lower in mice inoculated with RSV and treated with anti-RSV moAb at days 5 and
6 post-inoculation compared with RSV infected non-treated mice. Comparisons made by One way Analysis of Variance * p < 0.05. Red arrow
indicates the time of therapeutic intervention with anti-RSV moAb at 72 h post RSV inoculation.
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Page 9 of 11compartment, and this migration may explain the detec-
tion of RSV RNA in peripheral blood.
Despite that RSV antigens were detected in peripheral
monocytes, blood RSV RNA loads were inversely corre-
lated with blood CXCL1 (neutrophil chemoattractant)
and CCL2 (monocyte chemoattractant) on day 4 post-
inoculation and there were no correlations with IFN-g
and IL-4, key Th1/Th2 adaptive immunity cytokines
[19,29,34]. The fact that CXCL1 and CCL2 peaked early
on the infection when blood RSV RNA was detected at
very low levels, and inversely correlated with the peak of
RSV RNA loads on day 4 may reflect the different
dynamics of viral replication and cytokine production in
RSV disease.
Unexpectedly, the peak of blood RSV RNA loads did
not correlate with the severity of lung inflammation,
suggesting that the different components of RSV-
induced lung disease may have different pathogenic
mechanisms or follow different dynamics. It also sug-
gests that the detection of RSV RNA in the blood might
be an earlier event in disease pathogenesis that precedes
the establishment of severe pulmonary inflammation. If
this is the case, detection of RSV RNA in peripheral
blood may help identifying the more severe forms of
RSV disease in an early stage.
Our study has a number of limitations. We did not
document viral replication in the blood using traditional
cell culture, which may be due to the limited sensitivity
of the culture assay with small sample volumes. Never-
theless, RSV RNA was consistently detected only in per-
ipheral blood of mice inoculated with live RSV,
suggesting that live viral infection is required for patho-
genic viral dissemination. We further documented the
presence of RSV by a completely different methodology,
and identified a cell subtype, monocytes, bearing RSV
antigens in peripheral blood. It is possible that the high
RSV inoculum used caused severe lung inflammation
and cell damage with subsequent leakage of RSV parti-
cles, which may have been engulfed by peripheral blood
monocytes. However, the decrease of blood RSV RNA
loads after treatment directed against RSV suggests that
the detection of RSV RNA in peripheral blood truly
reflected the spread of the virus to the systemic com-
partment. Lastly, the identification of RSV RNA was
limited to the respiratory tract and peripheral blood but
not to other organs, which could have help to indirectly
assess the systemic spread of RSV during the acute
infection, and warrants further studies to determine
whether other organs are also affected in severe RSV
disease.
Acknowledgements
We acknowledge Emilio Flaño, PhD (Nationwide Children’s Hospital,
Columbus, OH) from his critical review of the manuscript and insightful
advice. Jason Skinner PhD (Baylor Institute for Immunology and Research,
Dallas, TX) and Samir Gupta MD (UT Southwestern Medical Center, Dallas,
TX) for their suggestions, and Evangeline Brock, (Children’s Medical Center,
Dallas, TX) for her help with viral cultures.
This work was presented in part at the 48
th Annual ICAAC/IDSA 46
th Annual
Meeting, Washington DC, October 25-28, 2008. AM was supported in part by
institutional grants and the RGK foundation. OR was supported in part by
research grants from Medimmune.
Author details
1Department of Pediatrics, Division of Infectious Diseases, University of Texas
Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.
2Department of Pathology, University of Texas Southwestern Medical Center
and Children’s Medical Center Dallas, 5323 Harry Hines Blvd, Dallas, TX
75390, USA.
3Department of Molecular Biology, University of Texas
Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.
4Medimmune Inc., One Medimmune way, Gaithersburg, MD 20878, USA.
5Department of Pediatrics, Division of Infectious Diseases and Center for
Vaccines and Immunity, The Research Institute at Nationwide Children’s
Hospital, The Ohio State University, 700 Children’s Drive, Columbus, OH
43205, USA.
Authors’ contributions
JPT: carried out and lead the experiments, performed data analysis and
drafted the manuscript. AMG: Carried out the immunohistochemical studies
and gave insightful advice to carry out the experiments. SK: carried out PCR
and culture assays. VGB, CT and MLC: performed mouse experiments,
pulmonary function tests studies and tissue culture. PAR and PAK: assistance
in study design data interpretation. OR participated in the design of the
study, data interpretation and helped to draft the manuscript. AM:
conceived the study, and participated in its design and coordination, helped
with data analysis and interpretation and helped to draft the manuscript. All
authors have read and approved the final manuscript.
Competing interests
OR has served as a consultant and has received research grants from Merck,
Medimmune and Abbott. PAK was employee of Medimmune.
Received: 12 May 2010 Accepted: 15 September 2010
Published: 15 September 2010
References
1. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ:
Bronchiolitis-associated hospitalizations among US children, 1980-1996.
Jama 1999, 282:1440-1446.
2. Hall CB: Respiratory syncytial virus and parainfluenza virus. N Engl J Med
2001, 344:1917-1928.
3. Mejias A, Chavez-Bueno S, Ramilo O: Respiratory syncytial virus
pneumonia: mechanisms of inflammation and prolonged airway
hyperresponsiveness. Curr Opin Infect Dis 2005, 18:199-204.
4. Tripp RA, Oshansky C, Alvarez R: Cytokines and respiratory syncytial virus
infection. Proc Am Thorac Soc 2005, 2:147-149.
5. Sheeran P, Jafri H, Carubelli C, Saavedra J, Johnson C, Krisher K, Sanchez PJ,
Ramilo O: Elevated cytokine concentrations in the nasopharyngeal and
tracheal secretions of children with respiratory syncytial virus disease.
Pediatr Infect Dis J 1999, 18:115-122.
6. Bennett BL, Garofalo RP, Cron SG, Hosakote YM, Atmar RL, Macias CG,
Piedra PA: Immunopathogenesis of respiratory syncytial virus
bronchiolitis. J Infect Dis 2007, 195:1532-1540.
7. Eisenhut M: Extrapulmonary manifestations of severe respiratory
syncytial virus infection–a systematic review. Crit Care 2006, 10:R107.
8. O’Donnell DR, McGarvey MJ, Tully JM, Balfour-Lynn IM, Openshaw PJ:
Respiratory syncytial virus RNA in cells from the peripheral blood during
acute infection. J Pediatr 1998, 133:272-274.
9. Yui I, Hoshi A, Shigeta Y, Takami T, Nakayama T: Detection of human
respiratory syncytial virus sequences in peripheral blood mononuclear
cells. J Med Virol 2003, 70:481-489.
10. Rohwedder A, Keminer O, Forster J, Schneider K, Schneider E, Werchau H:
Detection of respiratory syncytial virus RNA in blood of neonates by
polymerase chain reaction. J Med Virol 1998, 54:320-327.
Torres et al. Respiratory Research 2010, 11:125
http://respiratory-research.com/content/11/1/125
Page 10 of 1111. Campbell APCJ, Kuypers J, Englund JA, Wald A, Guthrie KA, Corey L,
Boeckh M: Respiratory Virus Pneumonia after Hematopoietic Cell
Transplantation (HCT): Associations between Viral Load in
Bronchoalveolar Lavage Samples, Viral RNA Detection in Serum Samples,
and Clinical Outcomes of HCT. J Infect Dis 2010:1404-1412.
12. Burress CSEB, Barik S: An Infant with Respiratory Syncytial Virus
Bronchiolitis, Viremia and Hepatitis. J Investig Med 2008, 56:405.
13. Grant PR, Garson JA, Tedder RS, Chan PK, Tam JS, Sung JJ: Detection of
SARS coronavirus in plasma by real-time RT-PCR. N Engl J Med 2003,
349:2468-2469.
14. Xatzipsalti M, Kyrana S, Tsolia M, Psarras S, Bossios A, Laza-Stanca V,
Johnston SL, Papadopoulos NG: Rhinovirus viremia in children with
respiratory infections. Am J Respir Crit Care Med 2005, 172:1037-1040.
15. Poliakova TG, Ketiladze ES, Zhilina NN, Stakhanova VM: [Viremia in
influenza A2 (Hong Kong)]. Vopr Virusol 1970, 15:724-728.
16. Tsuruoka H, Xu H, Kuroda K, Hayashi K, Yasui O, Yamada A, Ishizaki T,
Yamada Y, Watanabe T, Hosaka Y: Detection of influenza virus RNA in
peripheral blood mononuclear cells of influenza patients. Jpn J Med Sci
Biol 1997, 50:27-34.
17. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN,
Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha do Q,
Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J: Fatal outcome of human
influenza A (H5N1) is associated with high viral load and
hypercytokinemia. Nat Med 2006, 12:1203-1207.
18. Mejias A, Chavez-Bueno S, Rios AM, Saavedra-Lozano J, Fonseca Aten M,
Hatfield J, Kapur P, Gomez AM, Jafri HS, Ramilo O: Anti-respiratory
syncytial virus (RSV) neutralizing antibody decreases lung inflammation,
airway obstruction, and airway hyperresponsiveness in a murine RSV
model. Antimicrob Agents Chemother 2004, 48:1811-1822.
19. Jafri HS, Chavez-Bueno S, Mejias A, Gomez AM, Rios AM, Nassi SS, Yusuf M,
Kapur P, Hardy RD, Hatfield J, Rogers BB, Krisher K, Ramilo O: Respiratory
syncytial virus induces pneumonia, cytokine response, airway
obstruction, and chronic inflammatory infiltrates associated with long-
term airway hyperresponsiveness in mice. J Infect Dis 2004,
189:1856-1865.
20. Chavez-Bueno S, Mejias A, Gomez AM, Olsen KD, Rios AM, Fonseca-Aten M,
Ramilo O, Jafri HS: Respiratory syncytial virus-induced acute and chronic
airway disease is independent of genetic background: an experimental
murine model. Virol J 2005, 2:46.
21. Estripeaut D, Torres JP, Somers CS, Tagliabue C, Khokhar S, Bhoj VG,
Grube SM, Wozniakowski A, Gomez AM, Ramilo O, Jafti HS, Mejias A:
Respiratory syncytial virus persistence in the lungs correlates with
airway hyperreactivity in the mouse model. J Infect Dis 2008,
198:1435-1443.
22. Mejias A, Chavez-Bueno S, Rios AM, Aten MF, Raynor B, Peromingo E,
Soni P, Olsen KD, Kiener PA, Gomez AM, et al: Comparative effects of two
neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies
in the RSV murine model: time versus potency. Antimicrob Agents
Chemother 2005, 49:4700-4707.
23. Wubbel L, Jafri HS, Olsen K, Shelton S, Barton Rogers B, Gambill G, Patel P,
Keyser E, Cassell G, McCracken GH: Mycoplasma pneumoniae pneumonia
in a mouse model. J Infect Dis 1998, 178:1526-1529.
24. Mejias A, Chavez-Bueno S, Raynor MB, Connolly J, Kiener PA, Jafri HS,
Ramilo O: Motavizumab, A Neutralizing Anti-Respiratory Syncytial Virus
(RSV) Monoclonal Antibody Significantly Modifies The Local And
Systemic Cytokine Responses Induced By RSV In The Mouse Model. Virol
J 2007, 4:109.
25. Fonseca-Aten M, Rios AM, Mejias A, Chavez-Bueno S, Katz K, Gomez AM,
McCracken GH Jr, Hardy RD: Mycoplasma pneumoniae induces host-
dependent pulmonary inflammation and airway obstruction in mice. Am
J Respir Cell Mol Biol 2005, 32:201-210.
26. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods
2001, 25:402-408.
27. Bont L, Heijnen CJ, Kavelaars A, van Aalderen WM, Brus F, Draaisma JT,
Geelen SM, van Vught HJ, Kimpen JL: Peripheral blood cytokine responses
and disease severity in respiratory syncytial virus bronchiolitis. Eur Respir
J 1999, 14:144-149.
28. Gill MALK, Kwon T, Muñiz L, Mejías A, Connolly J, Roy L, Banchereau J, and
Ramilo O: Differential recruitment of dendritic cells and monocytes to
respiratory mucosal sites in children with influenza and respiratory
syncytial virus infections. J Infect Dis 2008, 198:1667-1776.
29. Garofalo RP, Patti J, Hintz KA, Hill V, Ogra PL, Welliver RC: Macrophage
inflammatory protein-1alpha (not T helper type 2 cytokines) is
associated with severe forms of respiratory syncytial virus bronchiolitis. J
Infect Dis 2001, 184:393-399.
30. Esolen LM, Ward BJ, Moench TR, Griffin DE: Infection of monocytes during
measles. J Infect Dis 1993, 168:47-52.
31. Mori I, Komatsu T, Takeuchi K, Nakakuki K, Sudo M, Kimura Y: Parainfluenza
virus type 1 infects olfactory neurons and establishes long-term
persistence in the nerve tissue. J Gen Virol 1995, 76(Pt 5):1251-1254.
32. Domurat F, Roberts NJ Jr, Walsh EE, Dagan R: Respiratory syncytial virus
infection of human mononuclear leukocytes in vitro and in vivo. J Infect
Dis 1985, 152:895-902.
33. Valentova V, Psikal I, Kovarcik K: Demonstration of bovine respiratory
syncytial virus RNA in peripheral blood leukocytes of naturally infected
cattle. Acta Virol 2003, 47:33-36.
34. Mejias A, Chavez-Bueno S, Raynor MB, Connolly J, Kiener PA, Jafri HS,
Ramilo O: Motavizumab, a neutralizing anti-Respiratory Syncytial Virus
(Rsv) monoclonal antibody significantly modifies the local and systemic
cytokine responses induced by Rsv in the mouse model. Virol J 2007,
4:109.
doi:10.1186/1465-9921-11-125
Cite this article as: Torres et al.: Respiratory Syncytial Virus (RSV) RNA
loads in peripheral blood correlates with disease severity in mice.
Respiratory Research 2010 11:125.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Torres et al. Respiratory Research 2010, 11:125
http://respiratory-research.com/content/11/1/125
Page 11 of 11